Evidence map›Paper›PMID 31625693›Full record

ArticleDiagnostic cytopathology2020

Risk of malignancy and clinical outcomes of cyst fluid only nodules in the thyroid based on ultrasound and aspiration cytology.

Risa Kanematsu, Mitsuyoshi Hirokawa, Miyoko Higuchi, Ayana Suzuki, Hitomi Aga, Aki Tanaka, Naoki Yamao, Toshitetsu Hayashi, Seiji Kuma, Akira Miyauchi

Abstract read
In one paragraph

Article in Diagnostic cytopathology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Recent topics on thyroid cytopathology: reporting systems and ancillary studies.Journal of pathology and translational medicine · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Risa KanematsuDepartment of Clinical Laboratory, Kuma Hospital, Kobe, Hyogo, Japan.ORCID https://orcid.org/0000-0002-8365-1372
Mitsuyoshi HirokawaDepartment of Diagnostic Pathology and Cytology, Kuma Hospital, Kobe, Hyogo, Japan.
Miyoko HiguchiDepartment of Clinical Laboratory, Kuma Hospital, Kobe, Hyogo, Japan.
Ayana SuzukiDepartment of Clinical Laboratory, Kuma Hospital, Kobe, Hyogo, Japan.
Hitomi AgaDepartment of Clinical Laboratory, Kuma Hospital, Kobe, Hyogo, Japan.
Aki TanakaDepartment of Clinical Laboratory, Kuma Hospital, Kobe, Hyogo, Japan.ORCID https://orcid.org/0000-0001-9925-9992
Naoki YamaoDepartment of Clinical Laboratory, Kuma Hospital, Kobe, Hyogo, Japan.
Toshitetsu HayashiDepartment of Diagnostic Pathology and Cytology, Kuma Hospital, Kobe, Hyogo, Japan.
Seiji KumaDepartment of Diagnostic Pathology and Cytology, Kuma Hospital, Kobe, Hyogo, Japan.
Akira MiyauchiDepartment of Surgery, Kuma Hospital, Kobe, Hyogo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe number of extensive studies focusing on cyst fluid only (CFO) thyroid nodules is limited, and the risk of malignancy (ROM) in CFO nodules has not been well-established. Thus, the purpose of this study was to investigate CFO nodules using cytology and ultrasound. In addition, we sought to define the ROM and determine the recommended clinical management of CFO nodules.

methodsWe retrospectively reviewed cytological preparations of 678 nodules that were originally identified as CFO nodules, including conventional specimens in 209 nodules, liquid based cytology (LBC) specimens in 221 nodules, and both conventional and LBC specimens in 248 nodules. Ultrasound reports with representative photographs were also reviewed.

resultsOf the 678 CFO nodules, 214 (31.6%) were reclassified into other categories, including non-diagnostic/unsatisfactory (ND/UNS) except for CFO (n = 15), benign (n = 198), and malignant (n = 1). Conventional preparations (33.5%) were more frequently reclassified than LBC preparations (13.6%; P < .0001). Re-aspiration for diagnosis was performed for only one calcified nodule. The rates of surgical resection and malignancy were 3.0% and 0.2%, respectively. Based on American Thyroid Association guidelines and the Kuma Hospital ultrasound classification, worrisome sonographic features were identified in 5.8% and 0% of CFO nodules, respectively.

conclusionWe propose that CFO nodules should be classified as separate from ND/UNS nodules; they should be categorized as a subtype of benign nodules. However, it is essential that fine-needle aspiration cytology be performed under ultrasound-guided real-time visualization of needle placement in the target nodule in all cases.

Indexed as

Biopsy, Fine-NeedleCyst FluidCytodiagnosisHumansRetrospective StudiesThyroid Cancer, PapillaryThyroid GlandThyroid NeoplasmsThyroid NoduleUltrasonographyBethesda systemcyst fluid onlyfoamy cellspapillary thyroid carcinomaThyroid aspiration cytology

Identifiers

PMID31625693
PMCPMC6972650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.